ESR1 and breast cancer: For example, beclin-1-transfected breast cancer cells have lower sensitivity to the proliferative effects of the estrogen receptor agonist E2 and the growth-suppressive effects of tamoxifen, contributing to acquisition of resistance with a concomitant increase in autophagy [46].